Freestone Capital Holdings LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 35,099 shares of the healthcare conglomerate’s stock after buying an additional 205 shares during the quarter. UnitedHealth Group comprises about 0.6% of Freestone Capital Holdings LLC’s holdings, making the stock its 29th biggest holding. Freestone Capital Holdings LLC’s holdings in UnitedHealth Group were worth $17,756,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also modified their holdings of the stock. Raymond James Financial Inc. acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $1,914,740,000. Proficio Capital Partners LLC increased its holdings in shares of UnitedHealth Group by 76,830.4% in the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock valued at $955,388,000 after acquiring an additional 1,886,186 shares during the period. Accredited Investors Inc. increased its holdings in shares of UnitedHealth Group by 9,235.4% in the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after acquiring an additional 776,516 shares during the period. Caisse DE Depot ET Placement DU Quebec increased its holdings in shares of UnitedHealth Group by 129.7% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after acquiring an additional 581,324 shares during the period. Finally, State Street Corp increased its stake in UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after buying an additional 563,554 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Analysts Set New Price Targets
Several brokerages have issued reports on UNH. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Barclays lowered their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $629.32.
UnitedHealth Group Stock Up 0.3 %
UNH opened at $476.22 on Thursday. The firm has a 50 day moving average price of $514.58 and a 200 day moving average price of $554.81. The company has a market cap of $438.25 billion, a PE ratio of 30.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.76%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.
Insider Buying and Selling at UnitedHealth Group
In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Energy and Oil Stocks Explained
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- How is Compound Interest Calculated?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Why Invest in 5G? How to Invest in 5G Stocks
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.